1. A mutant of the major melon allergen, Cuc m 2, with reduced IgE binding capacity is a good candidate for specific immunotherapy.
- Author
-
Tordesillas L, Gamboa P, Sanz ML, Palacín A, Gómez-Casado C, Cuesta-Herranz J, Pacios LF, Salcedo G, and Díaz-Perales A
- Subjects
- Adolescent, Adult, Amino Acid Sequence, Antigens, Plant chemistry, Cells, Cultured, Conserved Sequence, Cucurbitaceae chemistry, Epitopes immunology, Female, Humans, Immunotherapy, Male, Molecular Sequence Data, Profilins chemistry, Sequence Alignment, T-Lymphocytes cytology, T-Lymphocytes immunology, Young Adult, Antigens, Plant immunology, Cucurbitaceae immunology, Immunoglobulin E immunology, Profilins immunology
- Abstract
Hypoallergenic mutants with reduced IgE-binding capacity but which show a similar T-cell response to the corresponding natural allergen are ideal tools for immunotherapy, for preventing a possible anaphylactic shock. An IgE conformational epitope has been identified in Cuc m 2, the major allergen and profilin from melon. Since this epitope is highly conserved in most pollen profilins, it may contribute to an explanation of cross-reactivity between pollen and food profilins. Mutants (Mut 1 and Mut 2) were generated by changing specific residues of the Cuc m 2 epitope to alanine, produced in Escherichia coli, and purified by chromatographic methods. Mut 1 showed a slight reduction in IgE binding but an allergenic activity that was similar to recombinant Cuc m 2, as measured by basophil activation test (BAT) and skin prick test (SPT). By contrast, Mut 2 displayed a substantial reduction in IgE-binding capacity (57%) and positive responses, as determined by BAT (33%) and SPT (50%), when compared to those of rCuc m 2. However, the T-cell proliferation and cytokine production induced by Mut 2 and rCuc m 2 were similar. Thus, this mutant represent potential candidate for immunotherapy of profilin allergies., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF